CymaBay Therapeutics, Inc. 4 SEC Filings

Filed On	Filing
22 Mar 2024	Form 4: Loewy Caroline M, Director Disposed of 283,460 Employee Stock Option (right to buy) (Disposition to Issuer)
22 Mar 2024	Form 4: McWherter Charles, President of R&D Returned 46,938 shares to the issuer · Disposed of 1,688,412 Employee Stock Option (right to buy) (Disposition to Issuer)
22 Mar 2024	Form 4: Lefebvre Eric, Director Disposed of 154,010 Employee Stock Option (right to buy) (Disposition to Issuer)
22 Mar 2024	Form 4: Dorling Janet, Director Disposed of 161,010 Employee Stock Option (right to buy) (Disposition to Issuer)
22 Mar 2024	Form 4: Shantharam Harish, Chief Financial Officer Returned 20,125 shares to the issuer · Disposed of 434,750 Employee Stock Option (right to buy) (Disposition to Issuer)
22 Mar 2024	Form 4: Dickinson Klara, Chief Regulatory Officer Returned 21,000 shares to the issuer · Disposed of 1,301,111 Employee Stock Option (right to buy) (Disposition to Issuer)
22 Mar 2024	Form 4: Quinlan Paul T, General Counsel Returned 70,262 shares to the issuer · Disposed of 682,968 Employee Stock Option (right to buy) (Disposition to Issuer)
22 Mar 2024	Form 4: Wills Robert James, Director Returned 30,000 shares to the issuer · Disposed of 332,460 Employee Stock Option (right to buy) (Disposition to Issuer)
22 Mar 2024	Form 4: Shah Sujal, Director Returned 406,670 shares to the issuer · Disposed of 4,025,981 Employee Stock Option (right to buy) (Disposition to Issuer)
22 Mar 2024	Form 4: Wiggans Thomas G, Director Disposed of 186,010 Employee Stock Option (right to buy) (Disposition to Issuer)
22 Mar 2024	Form 4: Emster Kurt Von, Director Returned 90,000 shares to the issuer · Disposed of 280,460 Employee Stock Option (right to buy) (Disposition to Issuer)
15 Mar 2024	Form 4: Shah Sujal, Director Received 139,119 shares by exercise or conversion ($656K)
15 Mar 2024	Form 4: Quinlan Paul T, General Counsel Received 41,824 shares by exercise or conversion ($330K)
14 Feb 2024	Form 4: Dorling Janet, Director Received 6,000 shares by exercise or conversion ($27.8K) · Sold 6,000 shares ($192K)
26 Jan 2024	Form 4: Shantharam Harish, Chief Financial Officer Received 20,125 shares as a grant or award · Granted 74,750 Employee Stock Option (right to buy)
26 Jan 2024	Form 4: Dickinson Klara, Chief Regulatory Officer Received 21,000 shares as a grant or award · Granted 78,000 Employee Stock Option (right to buy)
26 Jan 2024	Form 4: McWherter Charles, President of R&D Received 31,938 shares as a grant or award · Granted 118,625 Employee Stock Option (right to buy)
26 Jan 2024	Form 4: Quinlan Paul T, General Counsel Received 28,438 shares as a grant or award · Granted 105,625 Employee Stock Option (right to buy)
26 Jan 2024	Form 4: Shah Sujal, Director Received 96,250 shares as a grant or award · Granted 357,500 Employee Stock Option (right to buy)
26 Jan 2024	Form 4: Wills Robert James, Director Granted 14,010 Stock Option (right to buy)

Comments